Effect of gestational age on lymphocyte phenotypes in hospitalized preterm infants

Johannes Dirks1, Ingmar Fortmann2, Janina Marißen1

  • 1Department of Pediatrics, University Hospital Würzburg, Würzburg, Germany; German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Lübeck, Germany.

Insights

Preterm infants

Area of Science:

  • Neonatal immunology
  • Adaptive immunity development
  • Preterm infant health

Background:

  • Preterm infants are highly susceptible to infections.
  • Understanding adaptive immune development is key to addressing this vulnerability.

Purpose of the Study:

  • Define adaptive immune cell subset profiles in preterm infants.
  • Investigate the impact of gestational age and perinatal factors on immune development.

Main Methods:

  • Flow cytometric phenotyping of lymphocyte subsets in two German neonatal intensive care unit cohorts.
  • Analysis of 499 (cohort 1) and 78 (cohort 2) preterm infants (GA 22.9-36.4 weeks).
  • Utilized MetadeconfoundR to assess clinical condition effects on lymphocyte profiles.

Main Results:

  • Gestational age at birth significantly shapes lymphocyte subset profiles.
  • Lower gestational age infants showed lower CD4+ T helper cell frequencies and a more effector/regulatory phenotype.
  • Amniotic infection syndrome and complications of prematurity exacerbated this immature immune profile; female sex correlated with higher CD4+ T helper cells.

Conclusions:

  • Comprehensive characterization of adaptive immune development in preterm infants.
  • Gestational age is a primary determinant, modulated by perinatal factors.
  • Identified profiles serve as a reference for interpreting immune data and understanding clinical outcome associations.
Abstract

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
789
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
251
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
191